Marker related to generation of congenital megacolon and application of marker
A Hirschsprung's disease, marker technology, applied in the field of genetic engineering, to achieve the effect of high throughput, simple and fast operation, and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Screening of the present embodiment, Hirschsprung's disease-related gene markers, comprising the steps of:
[0054] (1) Sample collection: Following informed consent, and under the premise of the Ethics Committee agreed to collect four cases of Hirschsprung Hirschsprung's patients and normal intestinal tissue;
[0055] (2) Preparation of RNA samples: treated with Rnase R (. Epicentre, Inc) Step (1) Total RNA was digested tissues collected, removed and circular RNA enriched linear RNA;
[0056] (3) reverse transcribed and labeled: using the random primer method (Arraystar Super RNALabeling Kit; Arraystar) in step (2) RNA was reverse transcribed and labeled cRNAs obtained;
[0057] (4) hybridization: The labeled cRNAs hybridize to Arraystar Human circRNA Array v2 (8x15K, Arraystar) on the slide after washing, using an Agilent scanner G2505C chip is scanned;
[0058] (5) Data processing: Agilent feature extraction software (11.0.1.1 Version) analysis array image obtained using...
Embodiment 2
[0060] In this embodiment, samples were extracted RNA, including the steps of:
[0061] (1) Sample: Following informed consent, and under the premise of the Ethics Committee agreed to collect 15 cases of patients with Hirschsprung megacolon tissue and normal intestinal tissue;
[0062] (2) RNA Sample Extraction:
[0063] 1) comprises a reagent TRIZOL reagent (Invitrogen life technologies), chloroform (Shanghai Chemical Reagent Co.), isopropanol (Shanghai Chemical Reagent Co., Ltd.), 100% ethanol (Shanghai Chemical Reagent Co., Ltd.), 75% ethanol (in DEPC-treated formulated water), water and free RNA enzyme-free RNA enzyme glycogen (Invitrogen lifetechnologies);
[0064] 2) Take 70mg tissue samples, 1mL of TRIZOL reagent was added, and homogenized with an electric homogenizer;
[0065] 3) The homogenate samples were incubated at 20 ℃ 5min, 1mL of each sample homogenate TRIZOL reagent was added 0.2mL of chloroform, the tube cap tightly, shaken vigorously by hand for 15 seconds after...
Embodiment 3
[0070] This embodiment will be cDNA synthesized using RNA prepared in Example 2.
[0071] Reagents: RNA inhibitors (Epicentre), SuperScript TM III Reverse Transcriptase (Invitrogen), 5 × RT buffer (Invitrogen), 2.5mM dNTP mixture (dATP, dGTP, dCTP and dTTP each 2.5mM) (HyTest Ltd) and Primer (Invitrogen Biotechnology Co., Ltd).
[0072] Instrument: clean bench (Xun Haibo Medical Equipment Factory Co., Ltd.), DK-8D type electric thermostat bath (Hysen letter Experimental Instrument Co.), and GeneAmp PCR System 9700 (Applied Biosystems).
[0073] During operation comprising the steps of:
[0074] (1) An annealing mixture:
[0075]
[0076] (2) The mixture was placed in a water bath at 65 deg.] C 5min, placed on ice for 2min, after centrifugation, the centrifuge tube in the RT reaction solution were successively added:
[0077]
[0078] (3) mixed at 37 ℃ 1min, pipette pipetting gently mixed, incubated for 50 deg.] C 60min, 70 ℃ incubated for 15min to inactivate the enzyme, the cD...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


